Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease

JAMA Oncol. 2021 Aug 11;e214381. doi: 10.1001/jamaoncol.2021.4381. Online ahead of print.

Abstract

This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.